CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $28,000 | -17.6% | 15,330 | -8.4% | 0.00% | – |
| Q1 2022 | $34,000 | -19.0% | 16,735 | +9.2% | 0.00% | – |
| Q4 2021 | $42,000 | -46.2% | 15,330 | -12.2% | 0.00% | – |
| Q3 2021 | $78,000 | -28.4% | 17,465 | -7.6% | 0.00% | – |
| Q2 2021 | $109,000 | -6.8% | 18,895 | +13.3% | 0.00% | – |
| Q1 2021 | $117,000 | +24.5% | 16,675 | +2.8% | 0.00% | – |
| Q3 2020 | $94,000 | -12.1% | 16,222 | +2.3% | 0.00% | – |
| Q2 2020 | $107,000 | -23.0% | 15,862 | -27.5% | 0.00% | – |
| Q1 2020 | $139,000 | -80.7% | 21,892 | -54.7% | 0.00% | – |
| Q2 2019 | $721,000 | -88.8% | 48,313 | -81.4% | 0.00% | -100.0% |
| Q1 2019 | $6,438,000 | +618.5% | 259,389 | +419.2% | 0.00% | – |
| Q4 2018 | $896,000 | -66.5% | 49,960 | -45.3% | 0.00% | -100.0% |
| Q3 2018 | $2,678,000 | -88.1% | 91,273 | -81.5% | 0.00% | -90.0% |
| Q2 2018 | $22,482,000 | -50.1% | 494,444 | -42.0% | 0.01% | -50.0% |
| Q1 2018 | $45,036,000 | +39.2% | 852,951 | +79.2% | 0.02% | +33.3% |
| Q4 2017 | $32,362,000 | -18.4% | 475,878 | -1.2% | 0.02% | -21.1% |
| Q3 2017 | $39,678,000 | +1.2% | 481,494 | +15.0% | 0.02% | -5.0% |
| Q2 2017 | $39,211,000 | +77.0% | 418,764 | +20.4% | 0.02% | +81.8% |
| Q1 2017 | $22,147,000 | +1444.4% | 347,837 | +977.1% | 0.01% | +1000.0% |
| Q4 2016 | $1,434,000 | -46.9% | 32,294 | -56.9% | 0.00% | -50.0% |
| Q3 2016 | $2,699,000 | -77.0% | 74,895 | -41.3% | 0.00% | -71.4% |
| Q3 2015 | $11,723,000 | +29.1% | 127,484 | +23.3% | 0.01% | +40.0% |
| Q2 2015 | $9,083,000 | -52.8% | 103,358 | -60.1% | 0.01% | -54.5% |
| Q1 2015 | $19,230,000 | -21.5% | 259,052 | -40.8% | 0.01% | -21.4% |
| Q4 2014 | $24,499,000 | +746.0% | 437,509 | +585.2% | 0.01% | +600.0% |
| Q3 2014 | $2,896,000 | +1536.2% | 63,855 | +1395.4% | 0.00% | – |
| Q2 2014 | $177,000 | -97.9% | 4,270 | -96.5% | 0.00% | -100.0% |
| Q1 2014 | $8,488,000 | +2411.2% | 122,542 | +2082.4% | 0.01% | – |
| Q4 2013 | $338,000 | -63.3% | 5,615 | -63.0% | 0.00% | -100.0% |
| Q3 2013 | $921,000 | +1435.0% | 15,172 | +1583.9% | 0.00% | – |
| Q2 2013 | $60,000 | – | 901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |